Peripheral transscleral retinal diode laser for rubeosis iridis

Christina Flaxel, Genevieve B. Larkin, David B. Broadway, Penelope J. Allen, Peter K. Leaver

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: To evaluate the results of peripheral transscleral retinal diode photocoagulation with or without transscleral cyclodiode therapy in patients with rubeosis iridis with or without elevated intraocular pressure and no fundal view. Methods: Peripheral transscleral retinal diode photocoagulation was performed in 15 eyes of 13 patients in an attempt to promote regression of rubeosis. The fundus could not be seen in any of the 15 eyes, so conventional panretinal photocoagulation was not possible. Nine eyes had associated elevated intraocular pressure and were treated with concurrent transscleral diode cyclophotocoagulation. Results: All eyes showed regression of rubeosis. Of the nine eyes treated with combination therapy, six had stabilized intraocular pressure, and three developed hypotony. None of the eyes developed a peripheral retinal detachment, and one eye lost the ability to perceive light. Conclusions: This method is effective in treating patients with rubeosis iridis when the view of the fundus is inadequate for conventional panretinal photocoagulation and more extensive intraocular surgery is precluded. It may be combined with transscleral cyclophotocoagulation therapy to manage concurrent high intraocular pressure in rubeotic glaucoma, but this involves a risk of postoperative hypotony.

Original languageEnglish (US)
Pages (from-to)421-429
Number of pages9
JournalRetina
Volume17
Issue number5
StatePublished - 1997
Externally publishedYes

Fingerprint

Semiconductor Lasers
Light Coagulation
Intraocular Pressure
Retinal Detachment
Glaucoma
Therapeutics
Light

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Flaxel, C., Larkin, G. B., Broadway, D. B., Allen, P. J., & Leaver, P. K. (1997). Peripheral transscleral retinal diode laser for rubeosis iridis. Retina, 17(5), 421-429.

Peripheral transscleral retinal diode laser for rubeosis iridis. / Flaxel, Christina; Larkin, Genevieve B.; Broadway, David B.; Allen, Penelope J.; Leaver, Peter K.

In: Retina, Vol. 17, No. 5, 1997, p. 421-429.

Research output: Contribution to journalArticle

Flaxel, C, Larkin, GB, Broadway, DB, Allen, PJ & Leaver, PK 1997, 'Peripheral transscleral retinal diode laser for rubeosis iridis', Retina, vol. 17, no. 5, pp. 421-429.
Flaxel C, Larkin GB, Broadway DB, Allen PJ, Leaver PK. Peripheral transscleral retinal diode laser for rubeosis iridis. Retina. 1997;17(5):421-429.
Flaxel, Christina ; Larkin, Genevieve B. ; Broadway, David B. ; Allen, Penelope J. ; Leaver, Peter K. / Peripheral transscleral retinal diode laser for rubeosis iridis. In: Retina. 1997 ; Vol. 17, No. 5. pp. 421-429.
@article{bb6d9a5e49e046d1b087cc5700e40163,
title = "Peripheral transscleral retinal diode laser for rubeosis iridis",
abstract = "Purpose: To evaluate the results of peripheral transscleral retinal diode photocoagulation with or without transscleral cyclodiode therapy in patients with rubeosis iridis with or without elevated intraocular pressure and no fundal view. Methods: Peripheral transscleral retinal diode photocoagulation was performed in 15 eyes of 13 patients in an attempt to promote regression of rubeosis. The fundus could not be seen in any of the 15 eyes, so conventional panretinal photocoagulation was not possible. Nine eyes had associated elevated intraocular pressure and were treated with concurrent transscleral diode cyclophotocoagulation. Results: All eyes showed regression of rubeosis. Of the nine eyes treated with combination therapy, six had stabilized intraocular pressure, and three developed hypotony. None of the eyes developed a peripheral retinal detachment, and one eye lost the ability to perceive light. Conclusions: This method is effective in treating patients with rubeosis iridis when the view of the fundus is inadequate for conventional panretinal photocoagulation and more extensive intraocular surgery is precluded. It may be combined with transscleral cyclophotocoagulation therapy to manage concurrent high intraocular pressure in rubeotic glaucoma, but this involves a risk of postoperative hypotony.",
author = "Christina Flaxel and Larkin, {Genevieve B.} and Broadway, {David B.} and Allen, {Penelope J.} and Leaver, {Peter K.}",
year = "1997",
language = "English (US)",
volume = "17",
pages = "421--429",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Peripheral transscleral retinal diode laser for rubeosis iridis

AU - Flaxel, Christina

AU - Larkin, Genevieve B.

AU - Broadway, David B.

AU - Allen, Penelope J.

AU - Leaver, Peter K.

PY - 1997

Y1 - 1997

N2 - Purpose: To evaluate the results of peripheral transscleral retinal diode photocoagulation with or without transscleral cyclodiode therapy in patients with rubeosis iridis with or without elevated intraocular pressure and no fundal view. Methods: Peripheral transscleral retinal diode photocoagulation was performed in 15 eyes of 13 patients in an attempt to promote regression of rubeosis. The fundus could not be seen in any of the 15 eyes, so conventional panretinal photocoagulation was not possible. Nine eyes had associated elevated intraocular pressure and were treated with concurrent transscleral diode cyclophotocoagulation. Results: All eyes showed regression of rubeosis. Of the nine eyes treated with combination therapy, six had stabilized intraocular pressure, and three developed hypotony. None of the eyes developed a peripheral retinal detachment, and one eye lost the ability to perceive light. Conclusions: This method is effective in treating patients with rubeosis iridis when the view of the fundus is inadequate for conventional panretinal photocoagulation and more extensive intraocular surgery is precluded. It may be combined with transscleral cyclophotocoagulation therapy to manage concurrent high intraocular pressure in rubeotic glaucoma, but this involves a risk of postoperative hypotony.

AB - Purpose: To evaluate the results of peripheral transscleral retinal diode photocoagulation with or without transscleral cyclodiode therapy in patients with rubeosis iridis with or without elevated intraocular pressure and no fundal view. Methods: Peripheral transscleral retinal diode photocoagulation was performed in 15 eyes of 13 patients in an attempt to promote regression of rubeosis. The fundus could not be seen in any of the 15 eyes, so conventional panretinal photocoagulation was not possible. Nine eyes had associated elevated intraocular pressure and were treated with concurrent transscleral diode cyclophotocoagulation. Results: All eyes showed regression of rubeosis. Of the nine eyes treated with combination therapy, six had stabilized intraocular pressure, and three developed hypotony. None of the eyes developed a peripheral retinal detachment, and one eye lost the ability to perceive light. Conclusions: This method is effective in treating patients with rubeosis iridis when the view of the fundus is inadequate for conventional panretinal photocoagulation and more extensive intraocular surgery is precluded. It may be combined with transscleral cyclophotocoagulation therapy to manage concurrent high intraocular pressure in rubeotic glaucoma, but this involves a risk of postoperative hypotony.

UR - http://www.scopus.com/inward/record.url?scp=0031423737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031423737&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 421

EP - 429

JO - Retina

JF - Retina

SN - 0275-004X

IS - 5

ER -